Control of plasminogen‐activator inhibitor type 2 gene expression in the differentiation of monocytic cells
Open Access
- 1 April 1992
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 205 (1) , 203-209
- https://doi.org/10.1111/j.1432-1033.1992.tb16769.x
Abstract
Plasminogen‐activator inhibitor type 2 (PAI‐2) is a potent and primary inhibitor of urokinase‐type plasminogen activator. Its production in monocytic cells is thought to play an important role in the control of localized proteolysis at sites of invasion as occurs in the control of inflammatory processes, tumor invasion and cellular differentiation. Therefore, we have investigated the mechanisms responsible for the regulation of PAI‐2 gene expression in differentiating monocytic cells using the human promyelocytic cell line, HL‐60, as a model. These cells are induced to differentiate to a macrophage‐like phenotype in response to phorbol ester [4‐phorbol‐12‐myristate 13‐acetate (PMA)]. The levels of PAI‐2 mRNA are barely detectable in undifferentiated cells, however, activation with PMA is associated with a rapid induction of PAI‐2 transcripts, reaching a maximum of 25‐fold in 4 h. Nuclear run on assays demonstrate that this induction is related primarily to an enhanced rate of gene transcription. Inhibition of de novo protein synthesis by cycloheximide increases PAI‐2 mRNA levels in both resting (sevenfold) and PMA‐treated cells (fivefold) after 4 h, but has no detectable effect on the rate of PAI‐2 gene transcription. The initial apparent half‐life of the induced PAI‐2 mRNA, determined by actinomycin‐d‐decay experiments, is very short, 32 min, suggesting rapid turnover. Furthermore, the PAI‐2 mRNA transcript is stabilized in the presence of cycloheximide, with a fourfold increase in the observed half‐life. The results demonstrate that PAI‐2 gene expression is regulated through post‐transcriptional mechanisms in undifferentiated cells, while both transcriptional and post‐transcriptional events govern the level of PAI‐2 transcripts in cells differentiated along the monocytic pathway. Destabilization of the PAI‐2 transcript may be associated with (A + U)‐rich sequences found in the 3′‐untranslated region of PAI‐2 mRNA. The short half life and rapid, strong induction of PAI‐2 point to an important, perhaps crucial, role in the differentiation of monocyte cells.Keywords
This publication has 38 references indexed in Scilit:
- Plasminogen activator inhibitor type‐2 Is a major protein induced in human fibroblasts and SK‐MEL‐109 melanoma cells by tumor necrosis factorJournal of Cellular Physiology, 1990
- Chromosomal organization and localization of the human urokinase inhibitor gene: Perfect structural conservation with ovalbuminGenomics, 1990
- mRNA decay: Finding the right targetsCell, 1989
- Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the geneBiochemical and Biophysical Research Communications, 1988
- Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.The Journal of Experimental Medicine, 1988
- Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.Journal of Clinical Investigation, 1988
- Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneNature, 1984
- Novel properties of human monocyte plasminogen activatorEuropean Journal of Biochemistry, 1984
- Complete nucleotide sequence of the messenger RNA coding for chicken muscle glyceraldehyde-3-phosphate dehydrogenaseBiochemical and Biophysical Research Communications, 1984
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977